Health Care Services

ADICON HOLDINGS

Jefferies Maintains "Buy" Rating for Adicon Health, Sets Target Price at HKD 7.00

ADICON HOLDINGS released FY2025 Q3 earnings on March 25 (BJT), actual revenue HKD 747.67 M, actual EPS HKD -0.0067

ADICON HOLDINGS released FY2025 9 Months Earnings on March 25, 2026 (BJT) with actual revenue of HKD 2.123 B and EPS of HKD 0.0348

EdiGene Holdings Announces FY2025 Annual Results and Business Development

ADICON HOLDINGS released FY2025 Q4 earnings on March 25 Pre-Market (BJT), actual revenue HKD 760.57 M, actual EPS HKD -0.0106

ADICON HOLDINGS released FY2025 earnings on March 25 Pre-Market (BJT), actual revenue HKD 2.884 B (forecast HKD 2.916 B), actual EPS HKD 0.0282 (forecast HKD 0.1877)

ADICON HOLDINGS to Release FY2025 Annual Earnings on March 25, Pre-Market BJT, Forecast Revenue HKD 2.977 B, EPS HKD 0.1916

Edicon's Wholly-Owned Subsidiary Acquires 100% Equity of Cansino for $204 Million

EdiCom's wholly-owned subsidiary acquires Crown Bioscience International for $204 million

Adico Holdings Shows Strong Growth Resilience in Medical Testing Industry During Winter

ADICON HOLDINGS released FY2025 Q1 earnings on August 22 (BJT), actual revenue HKD 680.37 M, actual EPS HKD 0.0205

ADICON HOLDINGS released FY2025 Semi-Annual earnings on August 22 Pre-Market (BJT), actual revenue HKD 1.376 B, actual EPS HKD 0.0415

ADICON HOLDINGS released FY2025 Q2 earnings on August 22 Pre-Market (BJT), actual revenue HKD 695.33 M, actual EPS HKD 0.021

ADICON HOLDINGS to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)

Edicon Holding Achieves BBB ESG Rating

EdiKang Holding Acquires Suzhou Yuedeyouqin and Weikang Biotech, Stock Price Rises

Eddidcon Holdings Annual General Meeting

Eddicon Holding's Acquisition of Target Company's Equity Progress

Morgan Stanley Reiterates Overweight Rating on Adechsa Holdings

Edding Health Holdings Strategic Investment in Yunda Wei Kang and Yunda You Qin Equity

FAMEGLOW

CH DEMETER FIN

LUEN THAI

NEW GONOW RV

HUISHENG INTL

TJCD

REF HOLDINGS

HAICHANG HLDG

BEST FOOD HLDG

JIMU GROUP

09860

ADICON Holdings Limited has delayed sending its shareholder circular regarding the acquisition of Crown Bioscience International due to pending regulatory approvals and shareholder consent. Originally expected by April 30, 2026, the timeline will be revised as the company works with advisers to secure necessary consents. The acquisition's completion remains uncertain, impacting shareholders and potential investors. The latest analyst rating for ADICON stock (HK:9860) is a Buy with a price target of HK$7.00.

Tip Ranks

ADICON Delays Shareholder Circular as Crown Bioscience Deal Awaits Regulatory Approvals

513060

512170

516820

159883

08341

562600

ADICON HOLDINGS announced its full-year results for the year ended December last year, with revenue of RMB 2.638 billion, a year-on-year decrease of 9.5%. Net profit was RMB 18.443 million, a year-on-year decrease of 60.8%; earnings per share were RMB 0.03. No dividend was declared

AASTOCKS

Bosera Hang Seng Health Care ETF(QDII)

Hwabao WP CSI Medical Service ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

AESO HOLDING

ChinaAMC CSI All Share Health Care Devices ETF

"Performance" ADICON HOLDINGS annual net profit of 18.44 million RMB fell by more than 60%, no dividend declared

02575

00327

02225

02650

06090

01907

03928

00861

03636

XUANZHUBIO-B(02575) fell 13.72%, with a trading turnover 72.3 Million HKD, and a year-to-date fell 39%. PAX GLOBAL(00327) fell 13.15%, with a trading turnover 76.7 Million HKD, and a year-to-date fell 26.7%. JINHAI MED TECH(02225) fell 12.12%, with a trading turnover 19.0 Million HKD, and a year-to-date rose 62.4%.

Top Gainers&Losers

XUANZHUBIO-B

PAX GLOBAL

JINHAI MED TECH

ZHIDA TECH

BUTONG GROUP

CHINA RISUN GP

CHINA NEXT-GEN

DC HOLDINGS

JINXUN RESOURCE

Top 10 HK Stock Losers (3.20)

00863

02911

02635

02665

02652

00600

03887

01133

02655

OSL GROUP(00863) fell 18.71%, with a trading turnover 133.8 Million HKD, and a year-to-date fell 25.9%. CIDI(02911) fell 16.58%, with a trading turnover 15.0 Million HKD, and a year-to-date fell 3.9%. NUOBIKAN(02635) fell 16.41%, with a trading turnover 56.4 Million HKD, and a year-to-date rose 25.7%.

OSL GROUP

CIDI

NUOBIKAN

SEYOND

CF PHARMTECH

AXERA

HASHKEY HLDGS

HARBIN ELECTRIC

GUOXIA TECH

Top 10 HK Stock Losers (3.9)

02617

02618

02315

01757

02609

09995

00467

01866

01060

TRANSTHERA-B(02617) rose 43.53%, with a trading turnover 2.6 Billion HKD, and a year-to-date fell 19.9%. JD LOGISTICS(02618) rose 22.98%, with a trading turnover 1.4 Billion HKD, and a year-to-date rose 10.6%. BIOCYTOGEN-B(02315) rose 20.96%, with a trading turnover 142.6 Million HKD, and a year-to-date rose 54.8%.

TRANSTHERA-B

JD LOGISTICS

BIOCYTOGEN-B

GLOBAL CHI BC

BAYZED HEALTH

REMEGEN

UNITEDENERGY GP

CHINA XLX FERT

DAMAI ENT

Top 10 HK Stock Gainers (3.6)

ADICON Holdings Limited has announced the resignation of non-executive director Feng Janine Junyuan due to changes in work arrangements, with no disagreements reported. The company has appointed Li Bo, a managing director at Carlyle Asia, as a new non-executive director, enhancing strategic oversight in the healthcare sector. The latest analyst rating for ADICON stock (HK:9860) is a Buy, with a price target of HK$8.60. ADICON operates in the healthcare sector and is backed by The Carlyle Group’s Asia arm, focusing on growth and operational enhancement.

ADICON reshapes board as Carlyle Asia executive joins as non-executive director

02473

02669

02097

02630

06666

02442

09636

00108

02179

XXF(02473) fell 14.46%, with a trading turnover 286.1 Million HKD, and a year-to-date rose 48.1%. ADICON HOLDINGS(09860) fell 12.03%, with a trading turnover 105.9 Million HKD, and a year-to-date rose 22.7%. CHINA OVS PPT(02669) fell 11.93%, with a trading turnover 528.1 Million HKD, and a year-to-date fell 5.3%.

CHINA OVS PPT

MIXUE GROUP

VIGONVITA-B

EVERG SERVICES

EASY SMART GP

JF SMARTINVEST

GR LIFE STYLE

RECBIO-B

Top 10 HK Stock Losers (1.28)

00100

00326

02259

00866

03896

00336

02339

MINIMAX-WP(00100) rose 26.48%, with a trading turnover 1.6 Billion HKD, and a year-to-date rose 195.9%. CHINA STAR ENT(00326) rose 12.02%, with a trading turnover 35.9 Million HKD, and a year-to-date rose 67.8%. ZIJIN GOLD INTL(02259) rose 11.59%, with a trading turnover 3.1 Billion HKD, and a year-to-date rose 59.6%.

MINIMAX-W

CHINA STAR ENT

ZIJIN GOLD INTL

CHINA QINFA

KINGSOFT CLOUD

HUABAO INTL

BWI INT'L

Top 10 HK Stock Gainers (1.27)

02899

00700

09888

As of noon, the three major Hong Kong stock indices maintained an upward trend, with the Hang Seng Index, Hang Seng Tech Index, and the National Enterprises Index recording varying degrees of increase, particularly in the gold and technology sectors. Major leaders Tencent Holdings, Alibaba -W, ZIJIN MINING, and ZIJIN GOLD INTERNATIONAL saw significant gains. The various sectors showed divergence, with market hotspots concentrated in gold and pharmaceutical outsourcing, as active funds drove a structural market trend, resulting in an overall positive sentiment. Investors are paying attention to the impact of macro consumption and import-export data on future market trends

- As of midday, Hong Kong stock indices maintained an upward trend with the Hang Seng Index at 27,055.65, up 1.07%.  
- Significant movements included Tencent Holdings increasing 1.08%, while Alibaba rose 2.18%, reflecting varied sector performance amidst macroeconomic concerns over retail and unemployment.  
- Notably, Zijin Mining surged by 4.08% after announcing a major acquisition, highlighting strengthened positions within the gold sector amidst market differentiation and active capital flow.

Market Pulse

ZIJIN MINING

TENCENT

BIDU-SW

KUAISHOU-W

BILIBILI-W

BABA-W

JD-SW

MNSO

ZHAOJIN MINING

ZONQING LTD

SMIC

Hong Kong Stock Midday Review | Hang Seng Index rises 1.08%, with gold and technology sectors leading the gains; ZIJIN MINING surges 10.63%

00314

Asian equities, particularly penny stocks, are attracting investor interest due to their growth potential at lower price points. Notable picks include Ley Choon Group Holdings, Sipai Health Technology, and Adicon Holdings, each with unique market positions and financial health ratings. Ley Choon Group, with a market cap of SGD150.58 million, shows stability with no debt but a slight decline in net income. Sipai Health Technology, valued at HK$2.07 billion, is unprofitable but forecasts significant revenue growth. Adicon Holdings, with a market cap of HK$3.20 billion, also faces losses but maintains a solid financial position.

Simplywall

Ley Choon

SIPAI HEALTH

Asian Penny Stock Highlights: Ley Choon Group Holdings And 2 Other Noteworthy Picks

ADICON HOLDINGS(09860.HK)